Volume 1, Issue 2
Editorialp. 159
Extracorporeal shock waves and bone: can we shock the cells into growth?
Author(s): J Hausdorf & M Maier
Bulletin Boardp. 163
Efficacy of glucosamine and chondroitin sulfate linked to degree of pain
Author(s): BULLETIN BOARD
Drug Evaluationp. 167
Role of abetimus in systemic lupus erythematosus
Author(s): Manuja Joshi & Michael P Madaio
Case Reportp. 173
Gene therapy with the interleukin-1 receptor antagonist for the treatment of arthritis
Author(s): Christopher H Evans, Steven C Ghivizzani, Peter Wehling & Paul D Robbins
Review Articlep. 179
Hematopoietic and mesenchymal stem cell transplantation in autoimmune diseases
Author(s): Alan Tyndall & Francesco Dazzi
Review Articlep. 189
How does HLA-B27 affect susceptibility to spondyloarthropathy?
Author(s): Jane C Goodall & JSH Gaston
Review Articlep. 199
Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
Author(s): Olivier Bruyere & Jean-Yves Reginster
Review Articlep. 207
Meniscectomy and osteoarthritis: what is the cause and what is the effect?
Author(s): Martin Englund & L Stefan Lohmander
Review Articlep. 217
Novel hints on the pathogenesis of lupus from in vivo models
Author(s): Patrizia Rovere-Querini, Maria Grazia Sabbadini, Gabriele Di Comite & Angelo A Manfredi
Review Articlep. 225
Antimalarials in systemic lupus erythematosus: benefits beyond disease activity
Author(s): Rosa M Andrade & Graciela S Alarcon
Review Articlep. 235
New therapies for systemic lupus erythematosus: has the future arrived?
Author(s): Arvind Kaul, David D Cruz & Graham RV Hughes
Review Articlep. 249
Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
Author(s): Ryo Yamada, Akari Suzuki & Kazuhiko Yamamoto
Review Articlep. 259
Potential role of statins and PPARs in rheumatoid arthritis
Author(s): Karen MJ Douglas, Naveed Sattar & George D Kitas
